000 01572 a2200421 4500
005 20250515074350.0
264 0 _c20070921
008 200709s 0 0 eng d
022 _a0014-2980
024 7 _a10.1002/eji.200636212
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aNajar, Hossain M
245 0 0 _aTopical TLR9 agonists induce more efficient cross-presentation of injected protein antigen than parenteral TLR9 agonists do.
_h[electronic resource]
260 _bEuropean journal of immunology
_cAug 2007
300 _a2242-56 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdjuvants, Immunologic
_xadministration & dosage
650 0 4 _aAdministration, Oral
650 0 4 _aAdministration, Topical
650 0 4 _aAnimals
650 0 4 _aAntigen Presentation
_ximmunology
650 0 4 _aCross-Priming
_ximmunology
650 0 4 _aCytotoxicity, Immunologic
650 0 4 _aDNA
_xadministration & dosage
650 0 4 _aDendritic Cells
_ximmunology
650 0 4 _aEnzyme-Linked Immunosorbent Assay
650 0 4 _aImmunohistochemistry
650 0 4 _aImmunologic Memory
650 0 4 _aMice
650 0 4 _aOligodeoxyribonucleotides
650 0 4 _aOligonucleotides
_ximmunology
650 0 4 _aOvalbumin
_ximmunology
650 0 4 _aToll-Like Receptor 9
_xagonists
650 0 4 _aVaccines, Synthetic
700 1 _aDutz, Jan P
773 0 _tEuropean journal of immunology
_gvol. 37
_gno. 8
_gp. 2242-56
856 4 0 _uhttps://doi.org/10.1002/eji.200636212
_zAvailable from publisher's website
999 _c17169539
_d17169539